Plain-English translation of NCT04696081 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry — a organized database — that collects information from cancer patients who experience atrial fibrillation (a type of irregular heartbeat) during or shortly after their cancer treatment. Researchers want to understand how often serious heart problems occur in these patients over one year and what factors increase the risk.
Doctors know that irregular heartbeats happen fairly often in cancer patients receiving treatment, but very little is known about what serious heart complications follow these episodes. Current cancer treatment guidelines and heart disease guidelines don't adequately address this problem, so this registry aims to fill that gap.
You would enroll in this registry and have your medical information collected and followed for one year. This involves sharing your cancer treatment details, heart rhythm records, and any heart-related health events that occur during the study period. You may have regular check-ups or blood work as part of your normal cancer care, and this information would be contributed to the research database to help doctors learn more about managing heart complications in cancer patients.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
France
Sponsor
University Hospital, Caen
Collaborators
University Hospital, Marseille, France, Hospices Civils de Lyon, France
Enrollment target
~1,000 participants
Started
September 2021
Primary completion
September 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Joachim Alexandre, MD, PhD
Caen Normandy University Hospital, France